HER2 targeting by antibodies inhibited growth in association with persistent ROS generation, glutathione (GSH) depletion, reduction in NRF2 levels, and inhibition of NRF2 function in ovarian cancer cell lines. The gene discussed is ERBB2; the disease is ovarian cancer.